---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-039592"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:47:47.590992+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics CFO Brian Piekos resigns effective September 6, 2024

## Summary
- CFO Brian Piekos notified Company of resignation on Aug 27, 2024, to pursue other opportunity.
- Resignation effective September 6, 2024; no disagreement on financial reporting or accounting matters.
- Company has initiated search for a new Chief Financial Officer.

## SEC filing metadata
- accession: 0001140361-24-039592
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/0001140361-24-039592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/ef20035237_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-039592
- JSON: https://secwatch.observer/filing/0001140361-24-039592.json
- Plain text: https://secwatch.observer/filing/0001140361-24-039592.txt

## Key facts
- Executive change
  Brian Piekos resigned as Chief Financial Officer at Elicio Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the “Company”), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/0001140361-24-039592-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.